2300 Market | May 29, 2025
REGISTER NOW
REGISTER NOW
Ready to Take your Biotech Firm to the Next Level?
As the biotech industry accelerates, early-stage and scaling companies face critical decisions in venture capital and real estate. Molecule to Market is the must-attend event designed to help growing bio firms navigate these complexities and unlock the strategies needed for sustainable success.
Join us at 2300 Market, a premier new lab development by Breakthrough Properties. This exclusive event brings together biotech founders, investors, real estate leaders, and industry experts for a morning of high-impact learning, networking, and deal-making highlighted by:
Expert-Led Panels
Valuable Networking
2300 Market Insider Access
Investor & Founder Office Hours at StudioLabs by Breakthrough
to Market
Molecule
APPLY NOW
Sponsorship Opportunities
Gain Exclusive Access to High-Growth Biotech Companies with Cost Effective Options Starting at $1,000
Why Sponsor?
Targeted Exposure: Reach decision-makers in biotech who are actively seeking lab space and growth opportunities.
Brand Visibility: Gain recognition as a leader in biotech real estate through pre-event marketing and on-site branding.
VIP Networking: Connect directly with biotech executives, venture capitalists, and strategic partners looking to invest in the right location.
Download the Sponsorship Overview
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed ut labore et dolore magna exercitation ullamco lab.
AVEC UNDE SIT DOLOR
$400
REGISTER
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed ut labore et dolore magna exercitation ullamco lab.
AVEC UNDE SIT DOLOR
$300
REGISTER
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed ut labore et dolore magna exercitation ullamco lab.
AVEC UNDE SIT DOLOR
$200
REGISTER
The Essential Conference for Growing Biotech Firms
Register Now
Agenda At a Glance
7:45 - 8:25 Breakfast & Networking
8:30 - 8:45 Market Outlook
Jeffrey Myers | Research Director, Colliers Boston
8:45 - 9:15 Keynote
Jonathan Epstein, MD | Dean of Perelman School of Medicine, EVP of University of Pennsylvania Health System
9:15 - 10:00 Capital Catalysts: Powerhouse Programs Driving Biotech Forward
10:00 - 10:15 Coffee Break
10:15 - 11:00 From Spark to Scale: Inside Philly’s Biotech Incubators
11:00 - 11:45 Backing Biotech: Venture Capital Committed to the Future of Biotech
11:45 - 12:00 Closing Remarks
ALL DAY Visit the Resource Table & Program Exhibitors
POST CONFERENCE Investors and Founders Office Hours at StudioLabs
Stay behind post sessions for the opportunity to connect your great ideas to capital. Special access for investors and registered attendees only.
12:00 - 1:00 By Appointment Only
StudioLabs by Breakthrough (Lobby Level)
BOOKING NOW OPEN
Book your slot now →
Meet the Panelists
Denita Henderson
Managing Director
Sponsors
Location Sponsor
Contact Us
Join us at Molecule to Market to take your biotech firm to the next level
Register Now
Apply for Sponsorship Opportunity
APPLY NOW
Joseph Fetterman, Executive Vice President
PHONE +1 610 715 8488 EMAIL joseph.fetterman@colliers.com
Elizabeth Brand, Senior Marketing Director
PHONE +1 215 928 7582 EMAIL elizabeth.brand@colliers.com
What's on the Agenda
7:45 - 8:25 Breakfast & Networking Register, enjoy a complimentary breakfast, connect and get ready for the day ahead
8:30 - 8:45 Market Outlook Colliers Research Team
8:45 - 9:10 Keynote Speaker Speakers To Be Announced
9:10 - 9:50 Venture Capital Panel 1 Speakers To Be Announced
9:50 - 10:00 Stretch Break Take a break, catchup in our exhibitor hall
10:00 - 10:30 Incubator Panel Speakers To Be Announced
10:30 - 11:00 Venture Capital Panel 2 Speakers To Be Announced
11:00 - 11:15 Coffee Break Take a break, catchup in our exhibitor hall
11:45 - 12:00 Closing Remarks Joseph Fetterman, Colliers
ALL DAY Visit the Resource Table & Program Exhibitors
POST CONFERENCE Investors and Founders Office Hours at StudioLabs Stay behind post sessions for the opportunity to connect your great ideas to capital. Special access for investor and capital level attendees only.
11:45 - 12:00 By Appointment Only
StudioLabs by Breakthrough (Lobby Level)
Booking Opens May 1
LOCATION SPONSOR
REGISTER NOW
2300 Market | May 29, 2025
REGISTER NOW
2300 Market | May 29, 2025
VIEW EVENT MEDIA NOW!
2300 Market | May 29, 2025
From Spark to Scale: Inside Philly’s Biotech Incubators
Join us for an engaging panel discussion featuring leaders from Philadelphia’s top incubators. These visionary speakers will share insights on nurturing biotech innovation, supporting early-stage startups, and accelerating the journey from lab bench to commercial success.
Michelle Ottey, PhD
Global Head of Centers and Labs
Lou Kassa
Chief Executive Officer
Jessica Grondin
Director, Scientific Operations
Melina Blees
Business Operations & Strategy Director
Registration for Molecule to Market is free but limited, with priority given to early stage or scaling biotech companies. Other registrants subject to approval.
Additional Panels and Speakers to be Announced
Ready to Sponsor with Us? Learn More.
Meet the Panelists
Capital Catalysts: Powerhouse Programs Driving Biotech Forward
What happens when mission-driven capital meets cutting-edge science? This panel brings together leaders from major institutional and government-backed programs to explore how strategic investments, public-private partnerships, and translational infrastructure are accelerating biotech innovation. Hear how these capital catalysts identify opportunities, reduce risk, and guide discoveries toward real-world impact.
Carter Caldwell
Co-Investment Program Director
Eric Heil
Managing Partner
Rick Jones
Advisory Partner
Michael Diem
Senior Managing Director
Featured Speakers
Deborah Zajac
General Partner
Featured Speakers
Jonathan Epstein, MD
The Robert G. Dunlop Professor Dean, Perelman School of Medicine Executive Vice President, University of Pennsylvania for the Health System
Kicking off Molecule to Market, Dr. Jonathan Epstein will share a forward-looking vision of how groundbreaking science translates into real-world therapies. Dr. Epstein leads Penn Medicine’s $11.9 billion enterprise spanning education, research, and care. A nationally recognized physician-scientist in cardiology, stem cell biology, and epigenetics, he brings deep insight into how institutions can accelerate discovery, foster innovation, and bring transformative treatments to patients.
KEYNOTE SPEAKER
Jeffrey Myers
Research Director
Colliers | Life Sciences
MARKET OUTLOOK
OPENING REMARKS
Joseph Fetterman
Executive Vice President
Colliers | Life Sciences
Craig Gravitz
Director, Project Accelerator Transition Innovation Office
Meet the Panelists
Backing Biotech: Venture Capital Committed to the Future of Biotech
Early-stage biotech investing is as much about vision as it is about valuation. Join a panel of experienced venture capitalists as they discuss how they spot high-potential startups, navigate uncertainty, and help founders scale scientific breakthroughs into commercial success. A behind-the-scenes look at how today’s bold bets become tomorrow’s biotech leaders.
Meet the Panelists
MODERATOR
MODERATOR
Heather Steinman
PhD, MBA
SVP, Business Development & Executive Director, Technology Transfer
MODERATOR
Audrey Greenberg
Mayo Venture Partner
MODERATOR
Photo Gallery
Click to view full gallery of images
Thank you for making Molecule to Market a success
We’re grateful you joined us for Molecule to Market at 2300 Market by Breakthrough Properties. Your energy, insights, and engagement helped make the event a truly dynamic gathering of biotech leaders and innovators.
If you missed anything, or just want to relive the moments, check out the video recap, browse event photos, and download the featured presentations below.